INSIGHTS ON DRUG DEVELOPMENT
-
A Novel Patient-Derived Colorectal Cancer Organoid Platform
Patient-derived organoids are revolutionizing drug discovery by mimicking tumors and predicting therapeutic efficacy. Discover a scalable bioprocess that enhances reproducibility and cost-effectiveness to pave the way for broader adoption.
-
Platform Strategy For Improving Manufacturability And Efficacy In Bispecific Antibodies
Novel bispecific antibody engineering overcomes assembly and manufacturability challenges, enabling scalable production while preserving therapeutic function, stability, purity, and product quality.
-
Target Product Profile (TPP) Explained
Learn how to best align your development strategy, guide cross-functional decisions, and build a clear pathway from discovery to successful commercialization.
-
De-Risking Drug Development: Informatics-Supported Solid Form Selection
Learn how combining polymorph screening with structural informatics improves solid‑form selection, lowers development risk, and boosts confidence in long‑term stability and manufacturability.
-
Detect Low-Abundance GLP-1 Impurities With Greater Sensitivity8/24/2026
Low-level impurities can be difficult to resolve using conventional approaches. Discover how a Charged Surface 2.3 µm superficially porous Phenyl-Hexyl column enhances reversed-phase LC-MS analysis.
-
Automated Bioburden Testing Solution11/7/2025
Automation is transforming microbial quality control labs, boosting productivity, minimizing errors, and ensuring data integrity. Discover how digitalization is driving Pharma 4.0 and reshaping lab workflows.
-
Delving Into Gene Expression Data Analysis And Experimental Reproducibility3/5/2026
Scientific reproducibility is essential for credible research. Learn to navigate standardized frameworks, refine normalization techniques, and ensure your data remains transparent and verifiable.
-
Ask Us Anything: Mark Benger On Solid-State Strategies For Drug Development7/23/2026
Mark Benger, Site Director at Cambrex Edinburgh, on solid-state characterization as an insurance policy — front-loaded work that quietly determines whether a program survives the jump from kilos to tonnes.
-
Managing The Challenges Of Controlled Substance Manufacturing9/22/2026
How can manufacturers balance security, compliance, and supply continuity in controlled substance development and production?
DRUG DEVELOPMENT SOLUTIONS
-
A smarter approach to method selection helps labs reduce guesswork and maintain consistent results. Learn how structured workflows and guided optimization can support confident decisions.
-
Backed by trusted data and deep scientific expertise, learn how our adaptive approach ensures seamless progression from preclinical development to commercial manufacturing.
-
MaxPeak™ Premier Columns utilize MaxPeak High Performance Surfaces that are designed to increase analyte recovery, sensitivity, and reproducibility by minimizing analyte/surface interactions that can lead to sample losses.
-
Quality control is a critical component for ensuring safety, efficacy, and consistency in the development and production of biologics. This comprehensive list of strategies, techniques, workflows, and best-in-class products for developing biopharmaceuticals can help you navigate the complexities of biologics and simplify the manufacturing process. Improve your quality control procedures and optimize your biologics production process with tools and expertise relied upon by researchers worldwide.
-
Whether you're looking to boost performance, enhance your capabilities, or simply get consistent, high-quality results, HyClone™ peak expression medium and HyClone™ prime expression medium are the solutions for you.